Melinda A. Pruis
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Analysis of Serious Weight Gain in Patients Using Alectinib for ALK-Positive Lung Cancer.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 17, 2022
A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer.
Journal: The oncologist
Published: September 12, 2022
A phase 1 open-label study to assess the relative bioavailability of TAK-931 tablets in reference to powder-in-capsule in patients with advanced solid tumors.
Journal: Investigational new drugs
Published: August 24, 2022
Renal function-based versus standard dosing of pemetrexed: a randomized controlled trial.
Journal: Cancer chemotherapy and pharmacology
Published: July 10, 2022
Cardiac Toxicity of Alectinib in Patients With ALK+ Lung Cancer: Outcomes of Cardio-Oncology Follow-Up.
Journal: JACC. CardioOncology
Published: March 20, 2022
Overcoming Acquired Resistance Mutation MET D1228N to Crizotinib With Cabozantinib in NSCLC With MET Exon 14 Skipping Mutation.
Journal: JCO precision oncology
Published: January 07, 2022
Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing.
Journal: British journal of cancer
Published: October 21, 2021
MET immunochemistry: a reliable screening tool for MET exon 14 skipping mutations in non-small cell lung cancer?
Journal: Annals of translational medicine
Published: December 14, 2020
A Lung Cancer Patient with Dyspnea: Diagnostic Difficulties during the COVID-19 Pandemic.
Journal: Cancer cell
Published: October 17, 2020
Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer.
Journal: Cancers
Published: August 31, 2020
Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 20, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026